SpringWorks Therapeutics
SWTX
SWTX was delisted on the 30th of June, 2025.
144 hedge funds and large institutions have $2.82B invested in SpringWorks Therapeutics in 2021 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 61 increasing their positions, 43 reducing their positions, and 16 closing their positions.
42% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 43
19% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 16
1% more funds holding
Funds holding: 142 → 144 (+2)
0.53% more ownership
Funds ownership: 91.76% → 92.29% (+0.53%)
2% less capital invested
Capital invested by funds: $2.86B → $2.82B (-$43.4M)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $2.7M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$25.6M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$24.8M |
| 3 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$21.6M |
| 4 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$20.8M |
| 5 |
AG
Artal Group
Luxembourg
|
+$16.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$41M |
| 2 |
CCM
Consonance Capital Management
New York
|
-$19.4M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
-$12.5M |
| 4 |
CIBC Asset Management
Toronto,
Ontario, Canada
|
-$12.5M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$10M |
SWTX Hedge Fund Activity: Q4 2021 in Review
144 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in SpringWorks Therapeutics (SWTX) for Q4 2021, worth a combined $2.82B — down 1.5% from $2.86B a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new SWTX positions and 16 closed out — a net gain of 3 holders — while 61 added to existing stakes and 43 trimmed.
The largest buyer was Marshall Wace, adding an estimated $25.6M. The largest seller was Jennison Associates, exiting entirely with an estimated $41M sold.
- 144 institutional investors held SpringWorks Therapeutics (SWTX) as of Q4 2021, up from 142 in Q3 2021.
- Funds reported $2.82B of SpringWorks Therapeutics stock for Q4 2021, down 1.5% quarter-over-quarter.
- 19 funds opened new SpringWorks Therapeutics positions in Q4 2021 and 16 closed out, a net change of +3 holders.
- The largest SpringWorks Therapeutics buyer in Q4 2021 was Marshall Wace, an estimated $25.6M added.
- The largest SpringWorks Therapeutics seller in Q4 2021 was Jennison Associates, an estimated $41M sold.
Based on aggregated 13F filings for Q4 2021.